HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Successful treatment of Schnitzler syndrome with canakinumab.

AuthorsRobbie Pesek, Roger Fox
JournalCutis (Cutis) Vol. 94 Issue 3 Pg. E11-2 (Sep 2014) ISSN: 2326-6929 [Electronic] United States
PMID25279482 (Publication Type: Case Reports, Letter)
Chemical References
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Interleukin-1beta
  • canakinumab
Topics
  • Antibodies, Monoclonal (administration & dosage, therapeutic use)
  • Antibodies, Monoclonal, Humanized
  • Celiac Disease
  • Diabetes Mellitus, Type 2
  • Diagnosis, Differential
  • Female
  • Fever (etiology)
  • Humans
  • Hypothyroidism
  • Injections, Subcutaneous
  • Interleukin-1beta (antagonists & inhibitors)
  • Male
  • Middle Aged
  • Schnitzler Syndrome (complications, diagnosis, drug therapy)
  • Urticaria (etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: